Aurora Cannabis (ACB) Cash from Operations (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Cash from Operations of 2413000.0 for Q1 2026, down 64.34% year-on-year from 6767000.0 in Q1 2025, and down 87.99% on a QoQ basis from 20090000.0 in Q4 2025.
Aurora Cannabis (ACB) Cash from Operations (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Cash from Operations for 10 consecutive years, with 2413000.0 the latest figure, recorded in Q1 2026.
- Quarterly Cash from Operations fell 64.34% year-over-year to 2413000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 49914373.36 (up 184.58% YoY) and the FY2026 annual result came in at 5664416.07, down 129.86% from the prior year.
- Cash from Operations retreated to 2413000.0 in Q1 2026 per ACB's latest filing, from 20090000.0 in the prior quarter.
- Over the last five years, Cash from Operations for ACB reached as high as 20644373.36 in Q4 2024 and fell as low as 87260253.14 in Q4 2022.
- A 5-year average of 14290302.42 and a median of 15677141.52 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations plunged 740.21% — and 2024, when it soared 633.92%.
- Year by year, Cash from Operations stood at 87260253.14 in 2022, then surged by 95.57% to 3866595.01 in 2023, then surged by 633.92% to 20644373.36 in 2024, then decreased by 2.69% to 20090000.0 in 2025, then slumped by 87.99% to 2413000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 2413000.0, 20090000.0, and 6767000.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.41 Mn |
| Mar 31, 2026 | 2.41 Mn |
| Dec 31, 2025 | 20.09 Mn |
| Dec 31, 2025 | 20.09 Mn |
| Mar 31, 2025 | 6.77 Mn |
| Mar 31, 2025 | 6.77 Mn |
| Dec 31, 2024 | 20.64 Mn |
| Dec 31, 2024 | 20.64 Mn |
| Sep 30, 2024 | -18.25 Mn |
| Sep 30, 2024 | -18.25 Mn |
| Jun 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 8.38 Mn |
| Mar 31, 2024 | -15.68 Mn |
| Mar 31, 2024 | -15.68 Mn |
| Dec 31, 2023 | -3.87 Mn |
| Dec 31, 2023 | -3.87 Mn |
| Sep 30, 2023 | -23.04 Mn |
| Sep 30, 2023 | -23.04 Mn |
| Dec 31, 2022 | -87.26 Mn |
| Dec 31, 2022 | -87.26 Mn |